Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects



Status:Completed
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 75
Updated:2/11/2018
Start Date:February 20, 2017
End Date:January 16, 2018

Use our guide to learn which trials are right for you!

A 6-week, Randomized, Double-blind, Placebo-controlled, Two-arm, Parallel Methodology Study To Assess The Effect Of Liraglutide On Food Intake In Obese Subjects

This will be a randomized, double blind, placebo controlled, 2 arm, parallel group,
methodology study to assess the effect of 6 weeks of liraglutide administration on food
intake in obese subjects.


Inclusion Criteria:

- Males and female subjects;

- Body Mass Index 30-40 kg/m2;

Exclusion Criteria:

- Evidence of history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or
allergic disease (including drug allergises, but excluding untreated, asymptomatic,
seasonal allergies at time of dosing)
We found this trial at
1
site
?
mi
from
Orlando, FL
Click here to add this to my saved trials